Arav Amir, Patrizio Pasquale
FertileSafe Ltd, Ness Ziona, Israel.
Yale Fertility Center, Yale University, New Haven, CT, USA.
Clin Med Insights Reprod Health. 2019 Dec 3;13:1179558119884945. doi: 10.1177/1179558119884945. eCollection 2019.
Cryopreservation of ovarian tissue has been considered experimental for many years, but very recently the American Society of Reproductive Medicine is reviewing the process and perhaps soon will remove the label of "experimental" and recognize it as an established method for preserving female fertility when gonadotoxic treatments cannot be delayed or in patients before puberty or when there is desire to cryopreserve more than just few oocytes. This article discusses in detail the 3 methodologies used for cryopreservation: (a) slow freezing, (b) directional freezing, and (c) vitrification.
多年来,卵巢组织冷冻保存一直被视为实验性技术,但最近美国生殖医学学会正在审查这一技术流程,或许很快就会取消“实验性”这一标签,并将其认可为一种成熟的方法,用于在性腺毒性治疗无法推迟时、青春期前患者中或当人们希望冷冻保存的不止是少量卵母细胞时保存女性生育力。本文详细讨论了用于冷冻保存的三种方法:(a)慢速冷冻,(b)定向冷冻,以及(c)玻璃化冷冻。